-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroPace wins FDA approval for ECoG Assistant AI epilepsy feature

PUBT·05/29/2026 12:01:43
Listen to the news
NeuroPace wins FDA approval for ECoG Assistant AI epilepsy feature
  • NeuroPace won FDA clearance for ECoG Assistant, an AI feature to speed clinician review of intracranial EEG data for its RNS System.
  • The model was trained on 124,450 epileptologist-labeled iEEG long-episode records, aiming to support faster treatment decisions.
  • NeuroPace also filed its next-generation cloud-based PDMS for FDA review, targeting approval in Q2 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuropace Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605290800BIZWIRE_USPR_____20260529_BW539764) on May 29, 2026, and is solely responsible for the information contained therein.